Class Central is learner-supported. When you buy through links on our site, we may earn an affiliate commission.

Stanford University

Statin-Associated Type 2 Diabetes - Who Gets It, Why, and Risk Assessment

Stanford University via YouTube

Start learning Write review
Boot.dev Ad

Learn Backend Development Part-Time, Online

Learn More → Corporate Finance Institute Ad

35% Off Finance Skills That Get You Hired - Code CFI35

Learn More →

Overview

Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore the relationship between statin usage and Type 2 diabetes in this informative lecture by Dr. Gerald Reaven from Stanford University. Learn about the risk factors, identification methods, and the overall benefits of statin treatment compared to the increased diabetes risk. Gain insights into who is most susceptible to statin-associated diabetes, why it occurs, and the extent of the risk involved. Understand how the advantages of statin therapy outweigh the potential drawbacks, providing a comprehensive view of this important medical topic.

Syllabus

Gerald Reaven, MD on Statin-Associated Type 2 Diabetes

Taught by

Stanford Health Care

Tags

Reviews

4.2 rating, based on 4 Class Central reviews

Start your review of Statin-Associated Type 2 Diabetes - Who Gets It, Why, and Risk Assessment

  • Omkar Sanjay Bhosale
    1
    Hello, my name is Omkar Bhosale, persuing Bachelor of Pharmacy in India. About this perticular course I've got some interesting things such as,It is an very informative course in which they have mentioned the benifits of the statin class of the lipid lowering drugs along with statins increases the 10% risk of type 2 diabetes, and different research studies done in people's are also explained in detail. I've learned something new and different from this course thank you.
  • Profile image for Mitali Nanoskar
    Mitali Nanoskar
    The YouTube lecture *"Statin-Associated Type 2 Diabetes – Who Gets It, Why, and Risk Assessment"* by Stanford University offers a concise, evidence-based overview of the link between statin therapy and type 2 diabetes. It effectively breaks down complex biochemical mechanisms and patient risk factors, making it accessible to both clinicians and informed viewers. The presenter clearly explains why certain individuals are more susceptible , and balances the discussion by emphasizing the cardiovascular benefits of statins. The risk assessment section is particularly valuable for clinical decision-making. Overall, it’s an informative, well-structured resource for anyone interested in personalized medicine and preventive cardiology.
  • Fouzia Jamil
    1
    I really amazed by the way he explained the things in a sequential way and also gives details by mentioning the related research papers.
  • Profile image for Sukamal Dey
    Sukamal Dey
    Very informative i got to know many thing about risk factors of diabetes with statin . And this session was very informative the way he presented was great
Start learning

Never Stop Learning.

Get personalized course recommendations, track subjects and courses with reminders, and more.

Sign up for free
Someone learning on their laptop while sitting on the floor.